Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries

The Lancet Diabetes and Endocrinology

Volumn 4, Issue 11, 2016, Pages 903-912

  Manne Goehler, Jennifer ^a,b   Atun, Rifat ^b   Stokes, Andrew ^c   Goehler, Alexander ^d   Houinato, Dismand ^e   Houehanou, Corine ^e   Hambou, Mohamed Msaidie Salimani ^f   Mbenza, Benjamin Longo ^f   Sobngwi, Eugène ^g   Balde, Naby ^h,i   Mwangi, Joseph Kibachio ^j   Gathecha, Gladwell ^j   Ngugi, Paul Waweru ^k   Wesseh, C Stanford ^l   Damasceno, Albertino ^m   Lunet, Nuno ⁿ   Bovet, Pascal ^o,p   Labadarios, Demetre ^q   Zuma, Khangelani ^q   Mayige, Mary ^r   Kagaruki, Gibson ^r   Ramaiya, Kaushik ^s   Agoudavi, Kokou ^t   Guwatudde, David ^u   Bahendeka, Silver K ^v   Mutungi, Gerald ^w   Geldsetzer, Pascal ^b   Levitt, Naomi S ^x   Salomon, Joshua A ^b   Yudkin, John S ^y   Vollmer, Sebastian ^b,z   Bärnighausen, Till ^b,aa,ab   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ABOMEY CALAVI   (Benin)

^f WALTER SISULU UNIVERSITY   (South Africa)

^g Hopital Central de Yaounde   (Cameroon)

^h Donka University Hospital   (Guinea)

ⁱ Ministry of Health   (Guinea)

^j MINISTRY OF HEALTH   (Kenya)

^k Kenya National Bureau of Statistics   (Kenya)

^l Health and Social Welfare   (Liberia)

^m EDUARDO MONDLANE UNIVERSITY   (Mozambique)

ⁿ University of Porto   (Portugal)

^o UNIVERSITY OF LAUSANNE   (Switzerland)

^p MINISTRY OF HEALTH   (Seychelles)

^q HUMAN SCIENCES RESEARCH COUNCIL   (South Africa)

^r NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^s Hindu Mandal Hospital   (Tanzania)

^t Ministry of Health of Togo   (Togo)

^u MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^v St Francis Hospital Uganda   (Uganda)

^w MINISTRY OF HEALTH   (Uganda)

^x UNIVERSITY OF CAPE TOWN   (South Africa)

^y UNIVERSITY COLLEGE LONDON   (United Kingdom)

^z UNIVERSITY OF GÖTTINGEN   (Germany)

^aa AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

^ab UNIVERSITY OF HEIDELBERG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AFRICA SOUTH OF THE SAHARA; AGE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE MARKER; ECONOMIC ASPECT; EDUCATION; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE; HEALTH CARE NEED; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COUNSELING; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SCREENING TEST; WEIGHT REDUCTION; YOUNG ADULT; ADOLESCENT; META ANALYSIS;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; DIABETES MELLITUS; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84992199745     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(16)30181-4     Document Type: Article

References (45)

1. 1 Lozano, R, Naghavi, M, Foreman, K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2095–2128.
2. 2 Danaei, G, Finucane, MM, Lu, Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378 (2011), 31–40.
3. 3 Atun, R, Gale, EA, The challenge of diabetes in sub-Saharan Africa. Lancet Diabetes Endocrinol 3 (2015), 675–677.
4. 4 Levitt, NS, Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 94 (2008), 1376–1382.
5. 5 Werfalli, M, Engel, ME, Musekiwa, A, Kengne, AP, Levitt, NS, The prevalence of type 2 diabetes among older people in Africa: a systematic review. Lancet Diabetes Endocrinol 4 (2016), 72–84.
6. 6 International Diabetes Federation. IDF Diabetes Atlas, 2015, International Diabetes Federation, Brussels, Belgium.
7. 7 Beran, D, Yudkin, JS, Diabetes care in sub-Saharan Africa. Lancet 368 (2006), 1689–1695.
8. 8 Knowler, WC, Barrett-Connor, E, Fowler, SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346 (2002), 393–403.
9. 9 Bennett, WL, Maruthur, NM, Singh, S, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 154 (2011), 602–613.
10. 10 Pal, K, Eastwood, SV, Michie, S, et al. Computer-based diabetes self-management interventions for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev, 3, 2013 CD008776.
11. 11 Gaede, P, Vedel, P, Larsen, N, Jensen, GV, Parving, HH, Pedersen, O, Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348 (2003), 383–393.
12. 12 Gaede, P, Vedel, P, Parving, HH, Pedersen, O, Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353 (1999), 617–622.
13. 13 Kooy, A, de Jager, J, Lehert, P, et al. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med 169 (2009), 616–625.
14. 14 Camara, A, Balde, NM, Sobngwi-Tambekou, J, et al. Poor glycemic control in type 2 diabetes in the south of the Sahara: the issue of limited access to an HbA1c test. Diabetes Res Clin Pract 108 (2015), 187–192.
15. 15 Beran, D, Perrin, C, Billo, N, Yudkin, JS, Improving global access to medicines for non-communicable diseases. Lancet Glob Health 2 (2014), e561–e562.
16. 16 Reich, MR, Harris, J, Ikegami, N, Maeda, A, Takemi, K, Evans, TG, Moving towards universal health coverage: lessons from 11 country studies. Lancet 387 (2016), 811–816.
17. 17 WHO. Health systems financing: the path to universal health coverage, 2010, World Health Organization, Geneva.
18. 18 Riley, L, Guthold, R, Cowan, M, et al. The World Health Organization STEPwise approach to noncommunicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health 106 (2016), 74–78.
19. 19 WHO. STEPS country reports. http://www.who.int/chp/steps/reports/en/, 2016 (accessed May 11, 2016).
20. 20 Davies, J, Yudkin, JS, Atun, R, Liberating data: the crucial weapon in the fight against NCDs. Lancet Diabetes Endocrinol 4 (2016), 197–198.
21. 21 Human Sciences Research Council. SANHANES: health and nutrition. http://www.hsrc.ac.za/en/research-areas/Research_Areas_PHHSI/sanhanes-health-and-nutrition, 2015 (accessed Dec 30, 2015).
22. 22 MoHSS and ICF International. The Namibia Demographic and Health Survey 2013, 2014, The Nambia Ministry of Health and Social Services (MoHSS) and ICF International, Windhoek, Namibia, and Rockville, Maryland, USA.
23. 23 WHO. The STEPS instrument and support materials. http://www.who.int/chp/steps/instrument/en/, 2015 (accessed Dec 11, 2015).
24. 24 Baragou, S, Djibril, M, Atta, B, Damorou, F, Pio, M, Balogou, A, Prevalence of cardiovascular risk factors in an urban area of Togo: a WHO STEPS-wise approach in Lome, Togo. Cardiovasc J Afr 23 (2012), 309–312.
25. 25 Stringhini, S, Viswanathan, B, Gedeon, J, Paccaud, F, Bovet, P, The social transition of risk factors for cardiovascular disease in the African region: evidence from three cross-sectional surveys in the Seychelles. Int J Cardiol 168 (2013), 1201–1206.
26. 26 Guwatudde, D, Mutungi, G, Wesonga, R, et al. The epidemiology of hypertension in uganda: findings from the national non-communicable diseases risk factor survey. PLoS One, 10, 2015, e0138991.
27. 27 Bahendeka, S, Wesonga, R, Mutungi, G, Muwonge, J, Neema, S, Guwatudde, D, Prevalence and correlates of diabetes mellitus in Uganda: a population-based national survey. Trop Med Int Health 21 (2016), 405–416.
28. 28 Camara, A, Balde, NM, Diakite, M, et al. High prevalence, low awareness, treatment and control rates of hypertension in Guinea: results from a population-based STEPS survey. J Hum Hypertens 30 (2016), 237–244.
29. 29 Kenya Ministry of Health Division of Non-Communicable Diseases and the Kenya National Bureau of Statistics. Kenya STEPwise survey for non-communicable diseases risk factors 2015 report, 2015, Kenya Ministry of Health, Kenya.
30. 30 Ministry of Health Seychelles. National survey of noncommunicable diseases in Seychelles 2013–2014 (Seychelles heart study IV): methods and main findings, 2015, Public Health Authority, Victoria, Seychelles.
31. 31 Houehanou, YC, Lacroix, P, Mizehoun, GC, Preux, PM, Marin, B, Houinato, DS, Magnitude of cardiovascular risk factors in rural and urban areas in Benin: findings from a nationwide steps survey. PLoS One, 10, 2015, e0126441.
32. 32 Silva-Matos, C, Gomes, A, Azevedo, A, Damasceno, A, Prista, A, Lunet, N, Diabetes in Mozambique: prevalence, management and healthcare challenges. Diabetes Metab 37 (2011), 237–244.
33. 33 American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care 37:suppl 1 (2014), S14–S80.
34. 34 WHO. Definition and diagnosis of diabetes and intermediate hyperglycemia, 2006, World Health Organization, Geneva.
35. 35 Society for Endocrinology Metabolism and Diabetes of South Africa. The 2012 SEMDSA guideline for the management of type 2 diabetes mellitus: summary, 2012, Society of Endocrinology, Metabolism and Diabetes in South Africa, South Africa.
36. 36 Sacks, DB, Bruns, DE, Goldstein, DE, Maclaren, NK, McDonald, JM, Parrott, M, Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48 (2002), 436–472.
37. 37 NCD Risk Factor Collaboration. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 387 (2016), 1513–1530.
38. 38 Stauffer, F, Viswanathan, B, Jean, M, Kinabo, M, Bovet, P, Comparison between capillary glucose measured with a Contour glucometer and plasma glucose in a population survey. Laboratoriumsmedizin 40 (2016), 133–139.
39. 39 UN Population Division. World population prospects, the 2015 revision. https://esa.un.org/unpd/wpp/2016, 2015 (accessed April 5, 2016).
40. 40 Clinical Guidelines Task Force. Global guideline for type 2 diabetes, 2012, International Diabetes Federation, Brussels.
41. 41 Mokdad, AH, Ford, ES, Bowman, BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003), 76–79.
42. 42 Cutler, DM, Lleras-Muney, A, Understanding differences in health behaviors by education. J Health Econ 29 (2010), 1–28.
43. 43 Republic of South Africa Department of Health. National health insurance for South Africa: towards universal health coverage. https://www.health-e.org.za/wp-content/uploads/2015/12/National-Health-Insurance-for-South-Africa-White-Paper.pdf, 2015 (accessed July 29, 2016).
44. 44 WHO. Universal health coverage: questions and answers. http://www.who.int/healthsystems/topics/financing/uhc_qa/en/, 2015 (accessed Dec 11, 2015).
45. 45 The Demographic and Health Surveys Program. Data: online tools. http://www.dhsprogram.com/, 2016 (accessed June 13, 2016).